ESMO Preceptorship on Gastric Cancer 2024: Singapore
- Start date
- 04 Dec 2024
- End date
- 05 Dec 2024
- Location
- Singapore, Republic of Singapore
- Application deadline
- Closed
Learning objectives
- To learn the fundamental of epidemiology, aetiology, pathogenesis, molecular events, and ethnic patterns as contributing factors to heterogeneity in gastric cancer (GC)
- To understand the importance of pathology and molecular factors
- To learn about best clinical practice in the multidisciplinary management of gastric and gastro-esophageal junction (GEJ) and esophageal squamous cell cancers in the adjuvant and metastatic settings
- To learn about current best practice for endoscopic and surgical resection of localised gastric cancer
- To be able to compare the benefits of neo-adjuvant, adjuvant approaches and the value of radiotherapy in the management of localised gastro-esophageal cancers
- To learn about the management of patients after progression, in special situations, and side effects of treatments
- To learn about the advances in the treatment and novel targets in gastric cancer
Download the preliminary programme
Co-Chairs
- Florian Lordick, Germany
- Sun Young Rha, Republic of Korea
How to apply
Application is via online form. During the application process you will be required to upload the following:
- Your CV including a list of your publications
- 3-5 slides presenting a clinical case (please use the ESMO Preceptorship Case Presentation Power Point template, provided here)
Application deadline
Application deadline has now closed.
Who can apply?
While this course is primarily aimed at oncologists resident in the Asia-Pacific region, application is open to all ESMO members.
To apply, ESMO membership is mandatory. If you are not an ESMO member or need to renew your membership, please visit the ESMO membership pages.
What's included?
Successful applicants will benefit from complimentary course registration and accommodation.
Travel Grant
In addition to the course registration and the hotel accommodation, a travel grant of maximum 600 euros is offered to selected applicants as a contribution versus their travel costs. The reimbursement will be processed after the course against original invoices/vouchers. Please be aware that visa costs are NOT covered by the travel grant and are the participant's responsibility.
Accreditation
The programme of this event has been accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Health and Safety Policy
It is each participant’s responsibility to check and comply with the latest health and travel regulations to ensure a smooth and safe journey from the Country of origin to the event venue, and back.
During the event, ESMO will apply health and safety protocols according to the latest local authority guidelines and regulations.
In general, ESMO recommends
- to apply health precautions and measures according to formal guidance and personal medical history
- to stay up to date with the vaccination status
- to perform a Rapid Antigen Test and wear a mask in case of symptoms
Hand sanitisers will be available throughout the venue; the use of mask is at own discretion in the absence of symptoms.
Any changes to the ESMO health and safety protocols will be communicated on this webpage.
Insurance
ESMO bears no responsibility for any untoward events in connection with, before, during and after the course. Participants are strongly advised to take out their own personal and travel coverage
Venue
Singapore, Republic of Singapore